Buchumschlag

CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Markert, Christoph (BerichterstatterIn) , Burhenne, Jürgen (BerichterstatterIn) , Weiß, Johanna (BerichterstatterIn) , Mikus, Gerd (BerichterstatterIn) , Haefeli, Walter E. (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Clinical pharmacology & therapeutics
Year: 2014, Jahrgang: 95, Heft: 3, Pages: 250-251
ISSN:1532-6535
DOI:10.1038/clpt.2013.188
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/clpt.2013.188
Volltext
Verfasserangaben:C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1496644158
003 DE-627
005 20220811191631.0
007 cr uuu---uuuuu
008 150223s2014 xx |||||o 00| ||eng c
024 7 |a 10.1038/clpt.2013.188  |2 doi 
035 |a (DE-627)1496644158 
035 |a (DE-576)426644158 
035 |a (DE-599)BSZ426644158 
035 |a (OCoLC)1340668257 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers  |c C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli 
264 1 |c 2014 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.02.2015 
700 1 |a Markert, Christoph  |d 1981-  |0 (DE-588)139752072  |0 (DE-627)61308649X  |0 (DE-576)312957777  |4 oth 
700 1 |a Burhenne, Jürgen  |d 1963-  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 oth 
700 1 |a Weiß, Johanna  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 oth 
700 1 |a Mikus, Gerd  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 oth 
700 1 |a Haefeli, Walter E.  |d 1958-  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 oth 
773 0 8 |i In  |t Clinical pharmacology & therapeutics  |d Hoboken, NJ : Wiley-Blackwell, 1960  |g 95(2014), 3, Seite 250-251  |h Online-Ressource  |w (DE-627)325793247  |w (DE-600)2040184-X  |w (DE-576)094531668  |x 1532-6535  |7 nnas  |a CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers 
773 1 8 |g volume:95  |g year:2014  |g number:3  |g pages:250-251  |g extent:2  |a CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers 
856 4 0 |u http://dx.doi.org/10.1038/clpt.2013.188  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20150223 
993 |a Article 
994 |a 2014 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |e 910000PM110903137  |e 910100PM110903137  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 139752072  |a Markert, Christoph  |m 139752072:Markert, Christoph  |d 910000  |d 910100  |e 910000PM139752072  |e 910100PM139752072  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1496644158  |e 2833526377 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"display":"Markert, Christoph","given":"Christoph","role":"oth","family":"Markert"},{"family":"Burhenne","role":"oth","given":"Jürgen","display":"Burhenne, Jürgen"},{"family":"Weiß","given":"Johanna","role":"oth","display":"Weiß, Johanna"},{"given":"Gerd","role":"oth","display":"Mikus, Gerd","family":"Mikus"},{"display":"Haefeli, Walter E.","given":"Walter E.","role":"oth","family":"Haefeli"}],"relHost":[{"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society for Clinical Pharmacology and Therapeutics"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Society for Pharmacology and Experimental Therapeutics"}],"id":{"issn":["1532-6535"],"doi":["10.1002/(ISSN)1532-6535"],"zdb":["2040184-X"],"eki":["325793247"]},"titleAlt":[{"title":"CPT"},{"title":"Clinical pharmacology and therapeutics"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1960 -"],"note":["Gesehen am 18.02.2016"],"recId":"325793247","part":{"issue":"3","volume":"95","pages":"250-251","year":"2014","extent":"2","text":"95(2014), 3, Seite 250-251"},"disp":"CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteersClinical pharmacology & therapeutics","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1960","publisherPlace":"Hoboken, NJ ; St. Louis, Mo. ; Basingstoke","dateIssuedDisp":"1960-","publisher":"Wiley-Blackwell ; Mosby ; Nature Publ. Group"}],"title":[{"subtitle":"CPT ; official publication of the American Society for Clinical Pharmacology and Therapeutics and the American Society for Pharmacology and Experimental Therapeutics","title_sort":"Clinical pharmacology & therapeutics","title":"Clinical pharmacology & therapeutics"}]}],"physDesc":[{"extent":"2 S."}],"name":{"displayForm":["C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli"]},"id":{"doi":["10.1038/clpt.2013.188"],"eki":["1496644158"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"title":[{"title":"CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers","title_sort":"CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1496644158","note":["Gesehen am 23.02.2015"]} 
SRT |a CYP2C9POLY2014 

Ähnliche Einträge